SCHEMBL6440238

SCHEMBL6440238

NS(=O)(=O)c1ccc(-c2c(COCCCO)n[nH]c2-c2ccc(Cl)cc2)cc1.[Na]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 9/20 0.42
CHRNA7 P36544 2/20 0.41
PTGS1 P23219 4/20 0.40
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
CA4 P22748 2/20 0.39
CA12 O43570 2/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
CA3 P07451 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
IKBKB O14920 1/20 0.36
CHUK O15111 1/20 0.36
EDNRB P24530 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3863226 1.00 PTGS2 (0.42) PTGS2CHRNA7PTGS1CA1CA2
SCHEMBL3863350 0.91 PTGS2 (0.43) PTGS2PTGS1CA1CA2CA9
SCHEMBL3866671 0.90 PTGS2 (0.42) PTGS2PTGS1CA1CA2CA9
SCHEMBL6439571 0.90 PTGS2 (0.42) PTGS2PTGS1EDNRBEDNRA
SCHEMBL3864964 0.86 CA12 (0.46) PTGS2CHRNA7PTGS1CA1CA2
SCHEMBL6438715 0.80 PTGS2 (0.41) PTGS2PTGS1
SCHEMBL6439628 0.78 PTGS2 (0.45) PTGS2PTGS1
SCHEMBL8602526 0.78 PTGS2 (0.47) PTGS2CHRNA7PTGS1CA1CA2
SCHEMBL6439532 0.77 PTGDR2 (0.41) PTGS2PTGS1EDNRBEDNRA
SCHEMBL6441773 0.77 PTGS2 (0.40) PTGS2PTGS1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534683-A4 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2005-08-24 EP disclosed
EP-1534683-A2 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2005-06-01 EP disclosed
WO-2004002409-A2 CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2004-01-08 WO disclosed